中国原创临床研究速递
Updates of Original Clinical Trials of Valvular Heart Disease from China
04/17 12:20-13:20
上海厅 (Room Shanghai)
-
12:20-13:20
-
12:20-13:20
-
12:20-12:30DragonFly-TFIM一年临床数据发布One-Year Clinical Outcomes of the DragonFly-TFIM
-
12:30-12:40TAVR术后单药抗血小板与抗凝的多中心、随机对照研究：TAORTA研究TAORTA Study: A Multicenter, Randomized Controlled Trial of Single Antiplatelet Therapy Versus Anticoagulation Following Transcatheter Aortic Valve Replacement
-
12:40-12:50TEER治疗二尖瓣反流交界区病变的多中心、随机对照研究：TEER-CD研究TEER-CD Study: A Multicenter, Randomized Controlled Trial of Transcatheter Edge-to-Edge Repair for the Treatment of Commissural Mitral Regurgitation
-
12:50-13:00Mi-thos®设计及注册临床研究一年随访结果
-
13:00-13:10NXT-DURA研究——首款非醛交联干瓣TaurusNXT-2年随访结果NXT-DURA Study: Two-Year Follow-Up Results of the TaurusNXT Valve—The First Non-Aldehyde Crosslinked, Dry Tissue Valve
-
13:10-13:20讨论